Biolife Solutions (BLFS) Net Income towards Common Stockholders (2010 - 2025)
Biolife Solutions (BLFS) posted quarterly Net Income towards Common Stockholders of $7.5 million for Q4 2025, down 37.1% year-over-year from $12.0 million in Q4 2024, and up 147.58% quarter-over-quarter from -$15.8 million in Q2 2025.
Biolife Solutions (BLFS) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Biolife Solutions (BLFS) has reported Net Income towards Common Stockholders for 16 consecutive years, with $7.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders fell 37.1% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at -$8.3 million (up 23.76% YoY), while the FY2025 annual figure was $7.5 million, up 166.88% from the prior year.
- Net Income towards Common Stockholders rose to $7.5 million in Q4 2025 per BLFS's latest filing, from -$15.8 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $12.0 million in Q4 2024 and bottomed at -$72.9 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$12.6 million across 5 years, with a median of -$10.2 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 13159.49% — and 2024, when it jumped 189.52%.
- Biolife Solutions' Net Income towards Common Stockholders stood at -$15.7 million in 2021, then slumped by 212.41% to -$49.2 million in 2022, then surged by 72.79% to -$13.4 million in 2023, then surged by 189.52% to $12.0 million in 2024, then plunged by 37.1% to $7.5 million in 2025.
- Business Quant data shows BLFS's Net Income towards Common Stockholders at $7.5 million in Q4 2025, -$15.8 million in Q2 2025, and -$448000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 45.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.54 Mn |
| Jun 30, 2025 | -15.84 Mn |
| Mar 31, 2025 | -448,000.00 |
| Dec 31, 2024 | 11.98 Mn |
| Sep 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | -20.72 Mn |
| Mar 31, 2024 | -10.22 Mn |
| Dec 31, 2023 | -13.38 Mn |
| Sep 30, 2023 | -29.13 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -13.71 Mn |
| Dec 31, 2022 | -49.19 Mn |
| Sep 30, 2022 | -10.32 Mn |
| Jun 30, 2022 | -72.88 Mn |
| Mar 31, 2022 | -7.42 Mn |
| Dec 31, 2021 | -15.75 Mn |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 7.88 Mn |
| Mar 31, 2021 | -1.12 Mn |
| Dec 31, 2020 | -2.81 Mn |